Nerve Conduction Velocity is Negatively Associated with Intima-media Thickness and Brachial-ankle Pulse Wave Velocity in Men with Type 2 Diabetes Mellitus

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Dec 21

PMID 30571795

Citations 4

Authors

Sayuri Tanaka

Ippei Kanazawa

Toshitsugu Sugimoto

Affiliations

Soon will be listed here.

Abstract

Objective: Previous studies suggest that the presence of diabetic peripheral polyneuropathy (DPN) is associated with atherosclerotic diseases; however, little is known about the relationship between diabetic nerve conduction velocity (NCV) versus arterial stiffness and atherosclerosis parameters.

Methods: The subjects in this study were 292 men with type 2 diabetes mellitus (T2DM). All subjects underwent NCV examination at median and tibial nerves as motor nerve (MCV) as well as median and sural nerves as sensory nerve (SCV). Brachial-ankle pulse wave velocity (baPWV) and carotid intima-media thickness (IMT) were evaluated as arterial stiffness and atherosclerosis parameters.

Results: Pearson's correlation coefficient showed that NCV at all sites negatively correlated with baPWV, maximal and mean IMT (IMT-Max and IMT-Mean), and plaque score (all p values p<0.01 at least). Multiple regression analyses adjusted for confounding factors such as age, duration of diabetes, body mass index, HbA1c, fasting C-peptide, systolic blood pressure, HDL-cholesterol, LDL-cholesterol and albuminuria showed that the association of NCV with IMT-Max, ITM-Mean, and plaque score remained significant (all p values p<0.05 at least) except that between SCV at median and IMT-Max. Moreover, SCV at median (forearm) and sural were significantly associated with baPWV (p = 0.023 and p = 0.027, respectively).

Conclusion: The present study showed that DPN estimated by quantitative NCV is linearly associated with the deterioration of arterial stiffness and atherosclerosis parameters in T2DM independently of various diabetic and atherosclerotic factors.

Citing Articles

Nerve conduction velocity studies in diabetic peripheral neuropathy involving sural nerve-A meta-analysis.

Prashant P, Pal S, Bansal A, Fotedar S J Family Med Prim Care. 2024; 13(10):4469-4475.

PMID: 39629397 PMC: 11610816. DOI: 10.4103/jfmpc.jfmpc_304_24.

The Association between the Severity of Distal Sensorimotor Polyneuropathy and Increased Carotid Atherosclerosis in Individuals with Type 2 Diabetes.

Hsieh D, Lai Y, Huang C, Ting C, Chiu W, Chen Y Diagnostics (Basel). 2024; 14(17).

PMID: 39272707 PMC: 11394250. DOI: 10.3390/diagnostics14171922.

Evaluating Diagnostic Ultrasound of the Vagus Nerve as a Surrogate Marker for Autonomic Neuropathy in Diabetic Patients.

Heiling B, Karl A, Fedtke N, Muller N, Kloos C, Grimm A Medicina (Kaunas). 2023; 59(3).

PMID: 36984526 PMC: 10058247. DOI: 10.3390/medicina59030525.

Association of arterial stiffness and neuropathy in diabetes: a systematic review and meta-analysis.

Beros A, Sluyter J, Scragg R BMJ Open Diabetes Res Care. 2023; 11(1).

PMID: 36746528 PMC: 9906264. DOI: 10.1136/bmjdrc-2022-003140.

References

Avest E, Stalenhoef A, de Graaf J . What is the role of non-invasive measurements of atherosclerosis in individual cardiovascular risk prediction?. Clin Sci (Lond). 2007; 112(10):507-16. View

Kim K, Lee B, Kim H, Shin J, Kang E, Cha B . Associations between cardio-ankle vascular index and microvascular complications in type 2 diabetes mellitus patients. J Atheroscler Thromb. 2011; 18(4):328-36. DOI: 10.5551/jat.5983. View

Kannel W, McGee D . Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979; 241(19):2035-8. DOI: 10.1001/jama.241.19.2035. View

Ishihara M, Kojima S, Sakamoto T, Kimura K, Kosuge M, Asada Y . Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus. Am J Cardiol. 2009; 104(6):769-74. DOI: 10.1016/j.amjcard.2009.04.055. View

Cruickshank K, Riste L, Anderson S, Wright J, Dunn G, Gosling R . Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation. 2002; 106(16):2085-90. DOI: 10.1161/01.cir.0000033824.02722.f7. View

Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K . Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes. 1996; 45 Suppl 3:S14-6. DOI: 10.2337/diab.45.3.s14. View

Brownrigg J, de Lusignan S, McGovern A, Hughes C, Thompson M, Ray K . Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus. Heart. 2014; 100(23):1837-43. DOI: 10.1136/heartjnl-2014-305657. View

Avci A, Demir K, Kaya Z, Marakoglu K, Ceylan E, Ekmekci A . Arterial stiffness and carotid intima-media thickness in diabetic peripheral neuropathy. Med Sci Monit. 2014; 20:2074-81. PMC: 4222449. DOI: 10.12659/MSM.892648. View

Gerstein H, Mann J, Yi Q, Zinman B, Dinneen S, Hoogwerf B . Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001; 286(4):421-6. DOI: 10.1001/jama.286.4.421. View

10.

Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S . Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2008; 94(1):45-9. DOI: 10.1210/jc.2008-1455. View

11.

Gerstein H, Miller M, Genuth S, Ismail-Beigi F, Buse J, Goff Jr D . Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011; 364(9):818-28. PMC: 4083508. DOI: 10.1056/NEJMoa1006524. View

12.

Hussain G, Rizvi S, Singhal S, Zubair M, Ahmad J . Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy. Diabetes Metab Syndr. 2014; 8(1):48-52. DOI: 10.1016/j.dsx.2013.02.003. View

13.

Yasuda H, Sanada M, Kitada K, Terashima T, Kim H, Sakaue Y . Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract. 2007; 77 Suppl 1:S178-83. DOI: 10.1016/j.diabres.2007.01.053. View

14.

Yokoyama H, Yokota Y, Tada J, Kanno S . Diabetic neuropathy is closely associated with arterial stiffening and thickness in Type 2 diabetes. Diabet Med. 2007; 24(12):1329-35. DOI: 10.1111/j.1464-5491.2007.02278.x. View

15.

Kim E, Moon S, Kim H, Lim D, Cho J, Kwon H . Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intima-media thickness in type 2 diabetes. Diabetes Care. 2011; 34(6):1403-5. PMC: 3114324. DOI: 10.2337/dc10-2222. View

16.

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

17.

Pop-Busui R, Evans G, Gerstein H, Fonseca V, Fleg J, Hoogwerf B . Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010; 33(7):1578-84. PMC: 2890362. DOI: 10.2337/dc10-0125. View

18.

Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman E . Inflammation as a Therapeutic Target for Diabetic Neuropathies. Curr Diab Rep. 2016; 16(3):29. PMC: 5127166. DOI: 10.1007/s11892-016-0727-5. View

19.

Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E . Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2014; 1(5):212-28. PMC: 4020724. DOI: 10.1111/j.2040-1124.2010.00074.x. View

20.

Cheung N, Wang J, Klein R, Couper D, Sharrett A, Wong T . Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007; 30(7):1742-6. DOI: 10.2337/dc07-0264. View